Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
In the last several years, global market of Sickle Cell Anemia Therapeutics developed rapidly, with an average growth rate of 13% during 2015 to 2019. In 2019, global revenue of Sickle Cell Anemia Therapeutics is nearly 1900 M USD.
This report elaborates on the current development of the Sickle-cell Anemia Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
GlycoMimetics
Emmaus Medical
Baxter
Daiichi Sankyo
Eli Lilly
Bluebird Bio
Mast Therapeutics
Pfizer
Selexys Pharmaceuticals
HemaQuest Pharmaceuticals
By Type:
Other
Vaccination and Antibiotics
Pain Medication
Folic Acid Supplementation
High Fluid Intake
By Application:
Hospitals
Other
Clinics
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Sickle-cell Anemia Therapeutics Market Overview 2018-2029
-
1.1 China Sickle-cell Anemia Therapeutics Industry Development Overview
-
1.2 China Sickle-cell Anemia Therapeutics Industry Development History
-
1.3 China Sickle-cell Anemia Therapeutics Industry Market Size (2018-2029)
-
1.4 China Sickle-cell Anemia Therapeutics Market Analysis by Type from Production Side
-
1.4.1 China Sickle-cell Anemia Therapeutics Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
1.4.2 China Sickle-cell Anemia Therapeutics Production Volume, Production Value and Growth Rate of Vaccination and Antibiotics (2018-2029)
-
1.4.3 China Sickle-cell Anemia Therapeutics Production Volume, Production Value and Growth Rate of Pain Medication (2018-2029)
-
1.4.4 China Sickle-cell Anemia Therapeutics Production Volume, Production Value and Growth Rate of Folic Acid Supplementation (2018-2029)
-
1.4.5 China Sickle-cell Anemia Therapeutics Production Volume, Production Value and Growth Rate of High Fluid Intake (2018-2029)
-
1.5 China Sickle-cell Anemia Therapeutics Market Analysis by Application from Consumption End
-
1.5.1 China Sickle-cell Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.2 China Sickle-cell Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.3 China Sickle-cell Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
1.6 China Sickle-cell Anemia Therapeutics Market Analysis by Region
-
1.6.1 North China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
Chapter 2 China Sickle-cell Anemia Therapeutics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Sickle-cell Anemia Therapeutics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Sickle-cell Anemia Therapeutics Market Status and Competition Analysis in 2023
-
2.2.3 China Sickle-cell Anemia Therapeutics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Sickle-cell Anemia Therapeutics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Sickle-cell Anemia Therapeutics Industry Development
Chapter 3 Sickle-cell Anemia TherapeuticsIndustry Chain Analysis
-
3.1 Sickle-cell Anemia Therapeutics Industry Chain
-
3.2 Sickle-cell Anemia Therapeutics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Sickle-cell Anemia Therapeutics Market
-
3.3 Sickle-cell Anemia Therapeutics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Sickle-cell Anemia Therapeutics Market
Chapter 4 China Sickle-cell Anemia Therapeutics Market, by Type
-
4.1 China Sickle-cell Anemia Therapeutics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Sickle-cell Anemia Therapeutics Total Production Volume and Growth Rate from Production Side
-
4.5 China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate, by Type
-
4.5.1 China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate of Other
-
4.5.2 China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate of Vaccination and Antibiotics
-
4.5.3 China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate of Pain Medication
-
4.5.4 China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate of Folic Acid Supplementation
-
4.5.5 China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate of High Fluid Intake
Chapter 5 China Sickle-cell Anemia Therapeutics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Sickle-cell Anemia Therapeutics Total Market Size and Growth Rate from Consumption End
-
5.5 China Sickle-cell Anemia Therapeutics Market Size and Growth Rate, by Application
-
5.5.1 China Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Hospitals
-
5.5.2 China Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Other
-
5.5.3 China Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Clinics
Chapter 6 China Sickle-cell Anemia Therapeutics Market, by Region
-
6.1 China Sickle-cell Anemia Therapeutics Production Volume and Production Value, by Region
-
6.2 China Sickle-cell Anemia Therapeutics Sales Volume and Sales Value, by Region
Chapter 7 North China Sickle-cell Anemia Therapeutics Market Analysis
-
7.1 North China Sickle-cell Anemia Therapeutics Market, by Type
-
7.2 North China Sickle-cell Anemia Therapeutics Market, by Application
Chapter 8 Central China Sickle-cell Anemia Therapeutics Market Analysis
-
8.1 Central China Sickle-cell Anemia Therapeutics Market, by Type
-
8.2 Central China Sickle-cell Anemia Therapeutics Market, by Application
Chapter 9 South China Sickle-cell Anemia Therapeutics Market Analysis
-
9.1 South China Sickle-cell Anemia Therapeutics Market, by Type
-
9.2 South China Sickle-cell Anemia Therapeutics Market, by Application
Chapter 10 East China Sickle-cell Anemia Therapeutics Market Analysis
-
10.1 East China Sickle-cell Anemia Therapeutics Market, by Type
-
10.2 East China Sickle-cell Anemia Therapeutics Market, by Application
Chapter 11 Northeast China Sickle-cell Anemia Therapeutics Market Analysis
-
11.1 Northeast China Sickle-cell Anemia Therapeutics Market, by Type
-
11.2 Northeast China Sickle-cell Anemia Therapeutics Market, by Application
Chapter 12 Southwest China Sickle-cell Anemia Therapeutics Market Analysis
-
12.1 Southwest China Sickle-cell Anemia Therapeutics Market, by Type
-
12.2 Southwest China Sickle-cell Anemia Therapeutics Market, by Application
Chapter 13 Northwest China Sickle-cell Anemia Therapeutics Market Analysis
-
13.1 Northwest China Sickle-cell Anemia Therapeutics Market, by Type
-
13.2 Northwest China Sickle-cell Anemia Therapeutics Market, by Application
Chapter 14 Company Profiles
-
14.1 GlycoMimetics
-
14.1.1 GlycoMimetics Company Profile
-
14.1.2 GlycoMimetics Sickle-cell Anemia Therapeutics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Emmaus Medical
-
14.2.1 Emmaus Medical Company Profile
-
14.2.2 Emmaus Medical Sickle-cell Anemia Therapeutics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Baxter
-
14.3.1 Baxter Company Profile
-
14.3.2 Baxter Sickle-cell Anemia Therapeutics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Daiichi Sankyo
-
14.4.1 Daiichi Sankyo Company Profile
-
14.4.2 Daiichi Sankyo Sickle-cell Anemia Therapeutics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Eli Lilly
-
14.5.1 Eli Lilly Company Profile
-
14.5.2 Eli Lilly Sickle-cell Anemia Therapeutics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Bluebird Bio
-
14.6.1 Bluebird Bio Company Profile
-
14.6.2 Bluebird Bio Sickle-cell Anemia Therapeutics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Mast Therapeutics
-
14.7.1 Mast Therapeutics Company Profile
-
14.7.2 Mast Therapeutics Sickle-cell Anemia Therapeutics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Pfizer
-
14.8.1 Pfizer Company Profile
-
14.8.2 Pfizer Sickle-cell Anemia Therapeutics Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Selexys Pharmaceuticals
-
14.9.1 Selexys Pharmaceuticals Company Profile
-
14.9.2 Selexys Pharmaceuticals Sickle-cell Anemia Therapeutics Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 HemaQuest Pharmaceuticals
-
14.10.1 HemaQuest Pharmaceuticals Company Profile
-
14.10.2 HemaQuest Pharmaceuticals Sickle-cell Anemia Therapeutics Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Sickle-cell Anemia Therapeutics Industry Research Conclusions
-
15.2 Sickle-cell Anemia Therapeutics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Sickle-cell Anemia Therapeutics Industry Market Size (2018-2029)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume, Production Value and Growth Rate of Vaccination and Antibiotics (2018-2029)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume, Production Value and Growth Rate of Pain Medication (2018-2029)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume, Production Value and Growth Rate of Folic Acid Supplementation (2018-2029)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume, Production Value and Growth Rate of High Fluid Intake (2018-2029)
-
Figure China Sickle-cell Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Sickle-cell Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China Sickle-cell Anemia Therapeutics Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
Figure North China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Central China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure South China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure East China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Sickle-cell Anemia Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Sickle-cell Anemia Therapeutics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Sickle-cell Anemia Therapeutics Market Share by Type in 2018
-
Figure China Sickle-cell Anemia Therapeutics Market Share by Type in 2023
-
Figure China Sickle-cell Anemia Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate of Other (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate of Vaccination and Antibiotics (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate of Pain Medication (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate of Folic Acid Supplementation (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume and Growth Rate of High Fluid Intake (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Market Share by Application in 2018
-
Figure China Sickle-cell Anemia Therapeutics Market Share by Application in 2023
-
Figure China Sickle-cell Anemia Therapeutics Total Market Size and Growth Rate from Consumption End
-
Figure China Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Other (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Clinics (2018-2023)
-
Table China Sickle-cell Anemia Therapeutics Production Volume by Region (2018-2023)
-
Table China Sickle-cell Anemia Therapeutics Production Volume Share by Region (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Production Volume Share by Region (2018-2023)
-
Table China Sickle-cell Anemia Therapeutics Production Value by Region (2018-2023)
-
Table China Sickle-cell Anemia Therapeutics Production Value Share by Region (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Production Value Share by Region (2018-2023)
-
Table China Sickle-cell Anemia Therapeutics Sales Volume by Region (2018-2023)
-
Table China Sickle-cell Anemia Therapeutics Sales Volume Share by Region (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Sales Volume Share by Region (2018-2023)
-
Table China Sickle-cell Anemia Therapeutics Sales Value by Region (2018-2023)
-
Table China Sickle-cell Anemia Therapeutics Sales Value Share by Region (2018-2023)
-
Figure China Sickle-cell Anemia Therapeutics Sales Value Share by Region (2018-2023)
-
Table North China Sickle-cell Anemia Therapeutics Production Volume by Type (2018-2023)
-
Table North China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Figure North China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Table North China Sickle-cell Anemia Therapeutics Sales Volume by Application (2018-2023)
-
Table North China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure North China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Central China Sickle-cell Anemia Therapeutics Production Volume by Type (2018-2023)
-
Table Central China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Central China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Table Central China Sickle-cell Anemia Therapeutics Sales Volume by Application (2018-2023)
-
Table Central China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Central China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Table South China Sickle-cell Anemia Therapeutics Production Volume by Type (2018-2023)
-
Table South China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Figure South China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Table South China Sickle-cell Anemia Therapeutics Sales Volume by Application (2018-2023)
-
Table South China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure South China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Table East China Sickle-cell Anemia Therapeutics Production Volume by Type (2018-2023)
-
Table East China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Figure East China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Table East China Sickle-cell Anemia Therapeutics Sales Volume by Application (2018-2023)
-
Table East China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure East China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Sickle-cell Anemia Therapeutics Production Volume by Type (2018-2023)
-
Table Northeast China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northeast China Sickle-cell Anemia Therapeutics Sales Volume by Application (2018-2023)
-
Table Northeast China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Sickle-cell Anemia Therapeutics Production Volume by Type (2018-2023)
-
Table Southwest China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Table Southwest China Sickle-cell Anemia Therapeutics Sales Volume by Application (2018-2023)
-
Table Southwest China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Sickle-cell Anemia Therapeutics Production Volume by Type (2018-2023)
-
Table Northwest China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Sickle-cell Anemia Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northwest China Sickle-cell Anemia Therapeutics Sales Volume by Application (2018-2023)
-
Table Northwest China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Sickle-cell Anemia Therapeutics Sales Volume Share by Application (2018-2023)
-
Table GlycoMimetics Company Profile
-
Table GlycoMimetics Sickle-cell Anemia Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Emmaus Medical Company Profile
-
Table Emmaus Medical Sickle-cell Anemia Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Baxter Company Profile
-
Table Baxter Sickle-cell Anemia Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Daiichi Sankyo Company Profile
-
Table Daiichi Sankyo Sickle-cell Anemia Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Sickle-cell Anemia Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Bluebird Bio Company Profile
-
Table Bluebird Bio Sickle-cell Anemia Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Mast Therapeutics Company Profile
-
Table Mast Therapeutics Sickle-cell Anemia Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Sickle-cell Anemia Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Selexys Pharmaceuticals Company Profile
-
Table Selexys Pharmaceuticals Sickle-cell Anemia Therapeutics Revenue, Price and Gross (2018-2023)
-
Table HemaQuest Pharmaceuticals Company Profile
-
Table HemaQuest Pharmaceuticals Sickle-cell Anemia Therapeutics Revenue, Price and Gross (2018-2023)
-
